Adagene completes enrollment in Phase 2 muzastotug dose-optimization trial for MSS colorectal cancerNov 9Trial updateAdagene Inccisplatin
Adagene reports mid-2026 results, muzastotug data across CRC and HCC trialsAug 12Quarterly updateAdagene Inc